Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,576 | 43,247 | 36,185 | 17,171 | 26,024 |
| Marketable Securities | 77,012 | 93,935 | 114,099 | 157,338 | 168,086 |
| Receivables | 3,352 | 2,775 | 13,177 | 3,432 | 2,419 |
| TOTAL | $124,180 | $143,080 | $167,247 | $182,936 | $201,204 |
| Non-Current Assets | |||||
| PPE Net | 2,942 | 3,316 | 3,567 | 3,958 | 4,060 |
| Intangibles | 1,569 | 1,605 | 1,642 | 1,678 | 1,715 |
| Other Non-Current Assets | 10,290 | 11,218 | 12,231 | 13,220 | 14,188 |
| TOTAL | $14,801 | $16,139 | $17,440 | $18,856 | $19,963 |
| Total Assets | $138,981 | $159,219 | $184,687 | $201,792 | $221,167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,422 | 611 | 1,964 | 1,458 | 1,705 |
| Accrued Expenses | 16,742 | 13,620 | 14,220 | 17,599 | 20,689 |
| TOTAL | $119,228 | $142,858 | $144,536 | $155,913 | $146,790 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 96,063 | 123,766 | 123,628 | 132,267 | 124,396 |
| Other Non-Current Liabilities | 9,649 | 10,878 | 12,088 | 13,278 | 13,354 |
| TOTAL | $43,205 | $47,588 | $71,831 | $93,326 | $125,615 |
| Total Liabilities | $162,433 | $190,446 | $216,367 | $249,239 | $272,405 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,259 | 78,118 | 77,919 | 67,722 | 66,989 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -710,455 | -716,191 | -709,657 | -723,448 | -724,285 |
| Other shareholders' equity | 40 | -4 | -10 | 95 | -63 |
| TOTAL | $-23,452 | $-31,227 | $-31,680 | $-47,447 | $-51,238 |
| Total Liabilities And Equity | $138,981 | $159,219 | $184,687 | $201,792 | $221,167 |